The Chemours Company (CC) vs Innospec Inc. (IOSP)
- The Chemours Company CC 12.61 −1.10%
- Innospec Inc. IOSP 77.67 −1.85%
The Chemours Company and Innospec Inc. are both Specialty Chemicals companies. The Chemours Company and Innospec Inc. are of similar size ($2.0B and $1.9B). The Chemours Company has negative trailing earnings, so its P/E is not meaningful; Innospec Inc. trades at 13.7×. Innospec Inc. grew revenue faster over the last twelve months: 4.73% against 0.10%. Innospec Inc. has the higher net margin (7.49% vs −2.64%) and the higher return on invested capital (9.12% vs 0.44%). Both pay a dividend; The Chemours Company yields more (2.78% vs 2.30%). Across the 22 metrics below, Innospec Inc. leads on 16 and The Chemours Company on 6.
Valuation
Profitability
| Metric | CC | IOSP | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.13% | 27.66% | 27.84% |
| Operating margin | 0.39% | 8.79% | 5.64% |
| Net margin | (2.64%) | 7.49% | 4.26% |
| Free cash flow margin | 3.49% | 1.94% | 4.75% |
| Return on equity | (67.54%) | 10.47% | 3.73% |
| Return on assets | (2.07%) | 7.68% | 1.16% |
| Return on invested capital | 0.44% | 9.12% | 3.21% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack